Open in app

Sign In

Write

Sign In

Atray Dixit
Atray Dixit

Home

About

Dec 1, 2021

Anti-precision medicine

drugging variability to create drugs that work on all patients Is there a way to turn a $40B/yr class of drugs that only works on about half of patients into a drug that works for all patients? We think the answer is YES. Three years ago we set out on…

Precision Medicine

3 min read

Anti-precision medicine
Anti-precision medicine
Precision Medicine

3 min read

Atray Dixit

Atray Dixit

CEO@Coral: patient diversity + improving therapies. MIT PhD 2018: single cell seq + CRISPR (Perturb-seq, Shuffle-seq)

Help

Status

Writers

Blog

Careers

Privacy

Terms

About

Text to speech